Form 8-K - Current report:
SEC Accession No. 0000950170-24-113764
Filing Date
2024-10-09
Accepted
2024-10-09 16:30:26
Documents
53
Period of Report
2024-10-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lxeo-20241009.htm   iXBRL 8-K 46091
2 EX-99.1 lxeo-ex99_1.htm EX-99.1 45835
3 GRAPHIC lxeo-ex99_1s1.jpg GRAPHIC 257044
4 GRAPHIC lxeo-ex99_1s2.jpg GRAPHIC 594340
5 GRAPHIC lxeo-ex99_1s3.jpg GRAPHIC 431683
6 GRAPHIC lxeo-ex99_1s4.jpg GRAPHIC 548837
7 GRAPHIC lxeo-ex99_1s5.jpg GRAPHIC 524298
8 GRAPHIC lxeo-ex99_1s6.jpg GRAPHIC 337052
9 GRAPHIC lxeo-ex99_1s7.jpg GRAPHIC 207012
10 GRAPHIC lxeo-ex99_1s8.jpg GRAPHIC 275398
11 GRAPHIC lxeo-ex99_1s9.jpg GRAPHIC 451422
12 GRAPHIC lxeo-ex99_1s10.jpg GRAPHIC 212580
13 GRAPHIC lxeo-ex99_1s11.jpg GRAPHIC 513812
14 GRAPHIC lxeo-ex99_1s12.jpg GRAPHIC 456363
15 GRAPHIC lxeo-ex99_1s13.jpg GRAPHIC 425005
16 GRAPHIC lxeo-ex99_1s14.jpg GRAPHIC 555952
17 GRAPHIC lxeo-ex99_1s15.jpg GRAPHIC 490209
18 GRAPHIC lxeo-ex99_1s16.jpg GRAPHIC 510420
19 GRAPHIC lxeo-ex99_1s17.jpg GRAPHIC 490425
20 GRAPHIC lxeo-ex99_1s18.jpg GRAPHIC 333118
21 GRAPHIC lxeo-ex99_1s19.jpg GRAPHIC 518172
22 GRAPHIC lxeo-ex99_1s20.jpg GRAPHIC 467925
23 GRAPHIC lxeo-ex99_1s21.jpg GRAPHIC 352497
24 GRAPHIC lxeo-ex99_1s22.jpg GRAPHIC 504487
25 GRAPHIC lxeo-ex99_1s23.jpg GRAPHIC 294598
26 GRAPHIC lxeo-ex99_1s24.jpg GRAPHIC 496308
27 GRAPHIC lxeo-ex99_1s25.jpg GRAPHIC 387908
28 GRAPHIC lxeo-ex99_1s26.jpg GRAPHIC 423212
29 GRAPHIC lxeo-ex99_1s27.jpg GRAPHIC 389815
30 GRAPHIC lxeo-ex99_1s28.jpg GRAPHIC 389227
31 GRAPHIC lxeo-ex99_1s29.jpg GRAPHIC 447356
32 GRAPHIC lxeo-ex99_1s30.jpg GRAPHIC 202785
33 GRAPHIC lxeo-ex99_1s31.jpg GRAPHIC 369065
34 GRAPHIC lxeo-ex99_1s32.jpg GRAPHIC 440915
35 GRAPHIC lxeo-ex99_1s33.jpg GRAPHIC 383257
36 GRAPHIC lxeo-ex99_1s34.jpg GRAPHIC 415311
37 GRAPHIC lxeo-ex99_1s35.jpg GRAPHIC 391287
38 GRAPHIC lxeo-ex99_1s36.jpg GRAPHIC 215753
39 GRAPHIC lxeo-ex99_1s37.jpg GRAPHIC 465498
40 GRAPHIC lxeo-ex99_1s38.jpg GRAPHIC 400639
41 GRAPHIC lxeo-ex99_1s39.jpg GRAPHIC 370579
42 GRAPHIC lxeo-ex99_1s40.jpg GRAPHIC 441360
43 GRAPHIC lxeo-ex99_1s41.jpg GRAPHIC 216093
  Complete submission text file 0000950170-24-113764.txt   23086320

Data Files

Seq Description Document Type Size
44 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT lxeo-20241009.xsd EX-101.SCH 25989
55 EXTRACTED XBRL INSTANCE DOCUMENT lxeo-20241009_htm.xml XML 4931
Mailing Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010 (212) 547-9879
Lexeo Therapeutics, Inc. (Filer) CIK: 0001907108 (see all company filings)

EIN.: 854012572 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41855 | Film No.: 241363091
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)